ANDA 75737, held by Perrigo New York. Minoxidil.
As of Nov 15, 2026, ANDA 75737 (Minoxidil Extra Strength (For Men)), held by Perrigo New York, was first approved by FDA on Mar 15, 2002, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 15, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Minoxidil Extra Strength (For Men)5% ยท solution;topical | Minoxidil | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
